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Gap junctionGap junctions, composed of proteins from the connexin gene family, are highly dynamic structures
that are regulated by kinase-mediated signaling pathways and interactions with other proteins.
Phosphorylation of Connexin43 (Cx43) at different sites controls gap junction assembly, gap junc-
tion size and gap junction turnover. Here we present a model describing how Akt, mitogen activated
protein kinase (MAPK) and src kinase coordinate to regulate rapid turnover of gap junctions. Specif-
ically, Akt phosphorylates Cx43 at S373 eliminating interaction with zona occludens-1 (ZO-1) allow-
ing gap junctions to enlarge. Then MAPK and src phosphorylate Cx43 to initiate turnover. We
integrate published data with new data to test and reﬁne this model. Finally, we propose that differ-
ential coordination of kinase activation and Cx43 phosphorylation controls the speciﬁc routes of
disassembly, e.g., annular junction formation or gap junctions can potentially ‘‘unzip’’ and be inter-
nalized/endocytosed into the cell that produced each connexin.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction to gap junctions
Vertebrate gap junctions are composed of proteins from the
connexin gene family (21 members in humans) [1–4]. These collec-
tions of intercellular channels permit passage of ions, amino acids,
nucleotides, metabolites and secondary messengers (e.g., calcium,
glucose, cAMP, cGMP, IP3) [5] between cells while macromolecules
are excluded (although small RNAs may pass [6,7]). Gap junction
intercellular communication is critically important in many cell
processes including control of cell proliferation, embryonic devel-
opment, cell differentiation and the coordinated contraction of
heart and smooth muscle [1,3,4,8–10]. Genetic linkage analysis
has implicated connexins in at least 14 human diseases – many
of which can be recapitulated in mutant connexin mouse models
[10]. Connexins are expressed in a tissue speciﬁc manner allowing
them to fulﬁll a variety of physiological roles. Connexin43 (Cx43),
the focus of this review, is by far the most abundantly and widely
expressed gap junction protein, and its essential role is highlighted
by the fact that Cx43 knockout mice die hours after birth [11]. Spe-
ciﬁc mutations in the Cx43 gene (GJA1) cause oculodentodigitaldysplasia (ODDD) with a variety of different symptoms including
small eyes, underdeveloped teeth, syndactyly and palmoplantar
keratoderma – a skin disease that can be caused by frame shift
mutations [12] that result in loss of the C-terminal region where
Cx43 is phosphorylated.
2. Connexin phosphorylation
Many connexins (e.g., Cx31, 32, 37, 40, 43, 45, 46, and 50) have
multiple phosphorylation sites – with Cx43 being the most preva-
lent and well studied. Connexins have 4 transmembrane domains
with the N- and C-termini on the cytoplasmic side. Cx43 is synthe-
sized and trafﬁcs through the ER like a typical integral membrane
protein but atypically delays oligomerization into a hexameric
hemi-channel or ‘‘connexon’’ until reaching the trans-Golgi net-
work [13]. The C-terminal region of Cx43 contains several ‘‘consen-
sus recognition sequences’’ for different kinases [14,15]. Truncated
Cx43 that lacks the C-terminal portion can form gap junctions but
their channels have different permeability/electrophysiological
properties [16,17]. Furthermore, truncated Cx43 has a prolonged
half-life and a ‘‘knock-in’’ mouse expressing truncated Cx43 had
rigid skin that readily peeled off, killing almost all homozygote
mutant mice shortly after birth [18]. In this mouse, Cx43 was
mis-localized throughout the stratiﬁed layers of the epidermis
unlike the normal basal restriction exhibited in wild type mice.
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insult (e.g., wounding, hypoxia)
Cx43 is abundantly expressed in skin and heart. Both tissues are
frequently injured, and Cx43 is known to play a key regulatory role
in repair processes [19–22].
3.1. Wound repair
Cx43 expression and phosphorylation status changes during
wound repair. Proliferation continually occurs in the basal layer
of the epidermis to replace dead keratinocytes and is up regulated
dramatically as a source of cells for wound repair. Wounding of the
epidermis activates changes in gap junctional communication that
synchronize cell migration across the wound bed [19,20,22]. Both
rodent [19] and human skin [20] show decreased connexin expres-
sion at the edge of a wound and a return to homeostatic levels
upon wound closure [19,23]. Although up to 9 connexins can be
expressed in epidermis, Cx43 is the predominant connexin
in vivo and in cultures of human keratinocytes [24] and may play
the primary role during early stages of wound healing as modula-
tion of Cx43 expression directly affects rates of wound repair.
Wound closure is delayed in diabetic skin when Cx43 expression
remains high [25] or upon Cx43 overexpression [26]. Mice with re-
duced levels of epidermal Cx43 show more rapid healing [27].
Cx43 antisense application to wounds accelerated keratinocyte
migration and wound repair resulting in less scarring [28]. At
24 h post wounding of human skin, PKC phosphorylation of Cx43
at S368 was dramatically increased, but strictly limited to the basal
cells that form a distinct communication compartment where pro-
liferation will occur over several days to replace dead/missing cells
[29]. These observations have translational implications as CoDa
Therapeutics and First String Research are testing different ways
of reducing Cx43 for use in human wound treatment. While
Cx43 modulation is critical for wound repair, we still lack a mech-
anistic understanding of the role it plays.
3.2. Cx43 regulation in the heart
Coordinated contraction of the heart requires myocytes to be
mechanically and electrically coupled. Electrical and chemical
coupling is largely maintained via gap junctions at a specialized
structure at the ends of myocytes referred to as the intercalated
disc [30,31]. The intercalated disc also contains desmosomes
and adherens junctions that provide mechanical stability [32,33]
and are closely juxtaposed with large gap junction plaques.
Immunoblot migrational analysis of lysates from normal heart
show that essentially all of the Cx43 protein is phosphorylated
[34–37]. Several labs have shown that ischemia promotes
dephosphorylation of Cx43 evidenced by a migration shift via
SDS–PAGE and that this corresponds to alterations in cardiomyo-
cyte coupling [34–37]. Analysis of speciﬁc phosphorylation sites
in mouse heart have shown that Cx43 is heavily phosphorylated
on casein kinase 1 (CK1) sites that promote gap junction assem-
bly [38,39] but upon ischemia, these CK1 sites are dephosphoryl-
ated [40] while phosphorylation on the PKC site at S368 is
increased [41,42]. In addition, rapid (5 min) dephosphorylation
of S365 occurs in response to ischemia [43], consistent with the
‘‘gatekeeper’’ concept where S365 and S368 phosphorylation
events are inversely related in vivo [44]. However, work in rat
[40] and rabbit [45] hearts show that S368 is phosphorylated un-
der baseline conditions and actually decreases upon ischemia,
indicating PKC interaction with Cx43 may show differences
between species.3.3. Cx43 phospho-site knock-in mice
Knock-in (KI) of Cx43 phosphoserine-site mutants (S to A) into
mice can prove the functional necessity for Cx43 phosphorylation
in vivo. Through combined utilization of phospho-speciﬁc antibod-
ies to query when and where Cx43 interacts with speciﬁc kinases
in tissue and the KI mice to discern the biological function of these
interactions we can better understand how Cx43 regulation affects
both cell and tissue biology. For example, mice containing Cx43
with S325/328/330A and S325/328/330D mutations showed dele-
terious effects on cardiac gap junction formation and function,
developed electric remodeling, and were highly susceptible to
inducible arrhythmias or were resistant to acute and chronic path-
ological gap junction remodeling, respectively [46]. A role for
MAPK phosphorylation of Cx43 during arteriole injury was shown
to be critical as mice expressing Cx43 with S255/262/279/282A
mutations show complete loss of proliferation and neointima for-
mation [47].4. Gap junctions are dynamic structures
As seen during injury, gap junctions are consistently and
rapidly remodeled or disassembled by a variety of stimuli. Gap
junctions appear as distinct, discernable, 0.1–5 lm long inter-
membrane structures via both electron and light microscopic
methods, while at the molecular level connexins exhibit a short
half-life. Cx43, the most ubiquitous and abundantly expressed
connexin, has a half-life of only 1–3 h [48–53] – much faster than
average turnover times for other integral membrane proteins (t1/
2 = 17–100 h in hepatocytes [54], t1/2 > 75 h in 3T3 cells [55]). The
dynamic nature of this protein results in a distinct membrane
structure in constant ﬂux. Studies utilizing Cx43 tagged with ﬂuo-
rescent proteins have highlighted the dynamic nature of gap junc-
tions [56,57]. These studies have shown that gap junctions
typically grow through lateral accretion of Cx43 oligomers from
the plasma membrane into the gap junction. This growth can
be balanced by constitutive internalization of subdomains of the
gap junction consisting of the oldest protein, presumably allowing
regulation of gap junction size [58]. Internalization of an entire
gap junction can also occur through a distinctive mechanism
where one cell internalizes a gap junction in its entirety via for-
mation of double membrane structure termed an annular junc-
tion [59–66] (see Fig. 1) or ‘‘connexisome’’ [67]. Gap junction
internalization can be triggered through a variety of stimuli
including wounding, ischemia, oncogene activation and growth
factor treatment. These stimuli also activate several kinase cas-
cades that result in Cx43 phosphorylation and lead to gap junc-
tion disassembly. Exactly how these sites promote disassembly
is not yet clear, but it is an active area of investigation in several
laboratories.5. Cx43 and interacting proteins
In addition to providing an intercellular conduit, the 130 amino
acid cytoplasmic tail of Cx43 interacts with a variety of signaling
and structural molecules leading to the concept of the gap junction
as a signaling nexus [68]. Gap junction dynamics and the ability of
Cx43 to interact with different proteins appear to be coordinated
through alterations in Cx43 phosphorylation.
Cx43 interacts with a range of proteins including cytoskeletal
elements (microtubules, MAGUK proteins ZO-1, ZO-2 and CASK)
and is phosphorylated by a variety of kinases (Akt, PKA, PKC,
ERK1/2, src).
Fig. 1. This model predicts phosphorylation at S373 promotes Cx43 accumulation into larger gap junctions with increased gap junction communication. Larger junctions
could promote annular junction formation through decreased membrane and energy restraints compared to that needed for smaller vesicles. Phosphorylation at S279/282
closes the gap junction and then Y247 phosphorylation initiates accumulation of the internalization machinery – a timeline consistent with the observed kinetics of
phosphorylation at these sites in response to epidermal growth factor (EGF) or phorbol esters (TPA).
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At least 19 phosphorylation sites have been identiﬁed on Cx43
present in cells or tissue, and the ﬁeld has made signiﬁcant pro-
gress in the characterization of the network of kinases that phos-
phorylate Cx43 (Table 1). Initial phosphorylation of Cx43 occurs
within 15 min of synthesis [49] so some phosphorylation events
likely can occur prior to Cx43 arrival at the plasma membrane. En-
hanced gap junction assembly occurs upon activation of cAMP-
dependent protein kinase (PKA) via increased Cx43 trafﬁcking to
the plasma membrane [50,69,70]. Work with monoclonal antibod-
ies which recognize primarily non-phosphorylated Cx43 (CT1 [43],
Zymed 13-8300 [71]) show that the transition of Cx43 from the
cytoplasm to the plasma membrane involves phosphorylation,
likely on S365 [43,44]. Subsequently, casein kinase 1 (CK1) phos-
phorylates Cx43 at S325/328/330 – sites involved in the movement
of Cx43 from the plasma membrane into the gap junction [38],
while activation of PKC can halt assembly of new junctions [50].
7. Akt mediated phosphorylation on S373 of Cx43 increases gap
junction size and inhibits interaction with ZO-1
Previously Akt has been shown to phosphorylate Cx43 on S373
[72]. Complementing these data, we recently found that increased
gap junction stability resulting from proteasomal inhibition
occurred through inhibition of Akt kinase turnover leading toTable 1
Conﬁrmed phosphorylation sites, putative kinases, their effects, and associated
references.
Sites Kinase Effect Refs.
Y247 Src Disassembly? [84]
S255 MAPK Gating [105]
S262 p34cdc2, MAPK Gating [106–108]
Y265 Src ?? [84]
S279/282 MAPK Gating [105]
S296 ?? ?? [40]
S297 ?? ?? [40]
S306 ?? Gating [40,109]
Y313 ?? ?? [110,111]
S325/328/330 CK1, ?? Assembly [38]
S364 ?? Assembly [70,112]
S365 ?? Assembly [44,113]
S368 PKC Gating, disassembly? [40,114,115]
S369 Akt, ?? ?? [72,112,113]
S372 ?? ?? [72,113,115]
S373 Akt GJ size [72,113,115,116]extensive Cx43 phosphorylation on S373 [73]. Direct inhibition of
Akt either via speciﬁc drugs or dominant negative constructs led
to loss of gap junctions. Phosphorylation of Cx43 at S373 by Akt ap-
pears to control gap junction size through inhibition of Cx43:ZO-1
interaction [74]. Data from the Gourdie lab has shown that ZO-1
interaction with Cx43 negatively regulates gap junction size [75].
In these experiments endogenous ZO-1:Cx43 interaction was out-
competed with a Cx43 C-terminal tail peptide mimetic resulting in
a dramatic increase in gap junction size [75]. This same mimetic
peptide was also effective in vivo where its application was able
to reduce gap junction remodeling and induced arrhythmia follow-
ing ventricular injury [76]. Notably, these data indicate that ZO-1 is
involved in the transition of Cx43 from the non-junctional plasma
membrane into the gap junction plaque. The observation by Park
et al. that Akt interacted with Cx43 at the edges of gap junctions
also support a role for Akt in this process [72]. Consistent with
these data, we found that cells expressing Cx43 with serine 373
mutated to aspartic acid, thus mimicking phosphorylation, make
large gap junctions and the mutant Cx43 could not interact with
ZO-1. Cells expressing S373A-Cx43, which did interact with ZO-1,
made small junctions [74]. Interestingly, inhibition of ZO-1:Cx43
interaction has been shown to promote phosphorylation on S368
by PKC [77] while conversely phosphorylation on S365 inhibits
S368 phosphorylation [44]. Though the relationship between
S365 and S373 phosphorylation is not yet clear, it does appear
these sites could serve to coordinate the interactions of Cx43 with,
not only ZO-1, but other proteins.8. Kinase activation program coordinates gap junction
disassembly
Cx43 trafﬁcking is coordinated through sequential phosphory-
lation events mediated by several different kinases. Under condi-
tions of injury or growth factor treatment, we ﬁnd that Cx43
becomes sequentially phosphorylated by Akt (at 5–15 min post
treatment on S373), MAPK (at 15–30 min on S279/S282) and Src
(at 30 min extending for hours on pY247) coincident with sequen-
tial changes in gap junctions, including increased gap junction size
followed by inhibition of gap junctional communication and
internalization of gap junctions from the plasma membrane. This
sequence of phosphorylation events and internalization is consis-
tent with what occurs during epidermal wounding where we ﬁnd
that gap junctional communication is necessary to initiate the
wound response [29] while rapid down regulation of gap
junctional communication and gap junctional internalization are
Fig. 2. Immunoﬂuorescent labeling of MDCK cells, expressing active v-src, with
antibodies to total Cx43 (described in [43]), shown in green, and Cx43 phosphor-
ylated on Y247 (described in [86]), shown in red. Panel B is a linescan showing
signal intensity for each antibody, on a pixel by pixel basis, on the segment of
cell:cell interface boxed in panel A. Panel C shows a magniﬁed image of the boxed
panel. Magniﬁcation bar: Panel A = 200 lm, Panel B = 20 lm.
Fig. 3. Immunoblot of LA-25 cells expressing temperature sensitive v-src incubated
at 40 C, where src is inactive () and 35 C, where src is active (+). Blots show levels
of total Cx43 [43], pY247 and pY265 [86], ERK, phospho-ERK (Cell Signaling, 4696
and 4370, respectively) and pS279/282 [86] and Akt, phospho-Akt (Cell Signaling,
2920 and 4060, respectively) and pS373 [74].
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Based on these data, we propose that gap junction disassembly is
driven by a kinase program that regulates the accumulation of
Cx43 into gap junctions in preparation for disassembly and ‘‘mark-
ing’’ of speciﬁc plaque domains for internalization via Cx43 phos-
phorylation at speciﬁc residues by at least 3 kinases. We refer to
this process as ‘‘acute internalization’’. Fig. 1 shows a model of
how these kinases may coordinate gap junction disassembly.
8.1. S373 phosphorylation leads to depletion of the
non-junctional pool of Cx43
The transient increase in gap junction size we observe during
acute turnover could serve at least 2 roles contributing to efﬁcient
internalization of gap junctions: (1) to deplete the plasma mem-
brane of non-junctional Cx43 by rapid incorporation into a gap
junction, and (2) to increase gap junction size, thus allowing more
efﬁcient internalization, possibly through formation of annular
junctions. This may also serve an important biological purpose;
as described above, keratinocytes require gap junction communi-
cation to initiate migration into a scratch wound [29] while down-
regulation of gap junctions is necessary for proper wound closure
[28]. This linkage of an increase in gap junction size to disassembly
could serve both of these functions. While it is not clear how these
pathways may be linked at the molecular level, it is interesting to
note that the Cx43:ZO-1 interaction is inhibited both by S373
phosphorylation [74] and by the interaction of Src with Cx43
[80,81].
8.2. Src activation promotes gap junction disassembly
Src has long been known to interact with and phosphorylate
Cx43 to promote downregulation of gap junction communication
and cause gap junction disassembly [82,83]. Src directly phosphor-
ylates Cx43 on Y247 and Y265 [84,85]. Using cells containing a
temperature-sensitive src we have found that phosphorylation
on these sites occurs on only a subset of gap junctions [86].
Fig. 2 shows immunostaining for pY247 in MDCK cells with active
Src (pY247 antibody in red and antibody to total Cx43 in green).
We found that the amount of pY247 in gap junctions varies, as
indicated by the spectrum of green to yellow to red labeling, result-
ing from increasing levels of phosphorylation. This variability is
shown quantitatively by a linescan (panel B) for one area of a cell:-
cell interface, which is shown magniﬁed in panel C. This variability
may represent gap junctions at varying steps in the disassembly
process. While many contiguous areas show an almost 1:1 ratio
of red to green ﬂuorescence intensity, several areas contain more
or less red than green (Fig. 2B, arrowheads). Though we can’t dis-
cern individual gap junctions at the light microscopy level, it is
interesting to consider that this staining pattern may indicate that
speciﬁc areas, or subdomains, of a gap junction are phosphorylated
and/or that accumulation of speciﬁc phosphorylation events trig-
ger recruitment of the disassembly apparatus, as indicated in our
model (Fig. 1). Distinct roles for acute and chronic effects of Src
mediated inhibition of gap junction communication have been
shown through work using Cx43 mutated at Y247 and/or Y265.
Phosphorylation on these tyrosines are necessary for gap junction
downregulation when v-src is chronically coexpressed with Cx43
[84,85]; however, acute activation of Src can lead to rapid down-
regulation of gap junction communication even when these sites
are absent. Instead, phosphorylation by MAPK on S279/S282 ap-
pears to mediate gap junction closure [39,41,87–91]. Consistent
with this, we have previously shown that Src activation leads to
phosphorylation of many other sites on Cx43, including S255,
S262, S279/282 and S368, indicating co-activation of MAPK and
PKC [86]. We show in Fig. 3 that Src activity alters the activation/phosphorylation status of ERK (shown by increased pERK signal
when Src is active) and Akt (shown by decreased pAkt signal
when src is active) and correspondingly we see increased
phosphorylation on pY247, pY265 and pS279/282 and decreased
phosphorylation on S373. Note, this is distinct from what we see
during acute internalization, where we observe a transient in-
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the case where there is a continuous or chronic disassembly signal,
the need for transient upregulation of gap junction communication
may be bypassed. For example, since Src can directly displace ZO-1
from binding to Cx43 [80,81] there may be no need for Akt phos-
phorylation to inhibit ZO-1 binding in preparation for consequent
interactions with PKC.
8.3. Phosphorylation of Cx43 affects channel permeability
While it is clear that Src, MAPK and PKC are all involved in
downregulation of gap junctions and gap junction communication,
just how these pathways are coordinated is not yet clear. As dis-
cussed above, v-src activation appears to have direct (pY247/
Y265) and indirect (MAPK activation) affects on Cx43 phosphoryla-
tion. Adding some complexity to this is the fact that v-src can bind
the region of Cx43 which is phosphorylated by MAPK [92]. Site di-
rected mutagenesis of the MAPK sites has consistently shown a
role for these residues in channel closure where phosphorylation
on these sites are able to decrease gap junction channel ‘‘open
time’’. Indeed, both src and MAPK activation yield gap junctions
with similar electrophysiological proﬁles [88]. We believe these
data support our model where coordinated Src and MAPK interac-
tion are important for gap junction downregulation at the channel
and turnover level. Channel selectivity can also be regulated
through phosphorylation. Phosphorylation on S368 by PKC altered
the permeability of channels, measured by both dye transfer and
changes in single channel conductance [41]. As noted above, dis-
placement of ZO-1 can increase PKC mediated phosphorylation at
S368 [93], thereby linking channel permeability to the assembly/
disassembly process. It also may be that speciﬁc routes of disas-
sembly, e.g., annular junction formation or constitutive turnover,
require differential coordination of kinase activation and Cx43
phosphorylation.9. Impact of Cx43 phosphorylation on tissue function and
exploitation for therapeutics
The identiﬁcation of phosphorylation sites on Cx43 and the
more recent introduction of phosphospeciﬁc antibodies and mu-
tant versions of Cx43 eliminating and mimicking phosphorylation
have led to detection of phosphorylation dependent changes in
Cx43 structure and localization [29,39,43,74,94–96], gap junction
channel gating properties [39,41,87–91], gap junction assembly
[39,44,73,94,96], and Cx43 interacting partners [43,47,97–100] in
cells and tissues. Thus, research is starting to go past a simple cor-
relation of unspeciﬁed phosphorylation-related migration shifts on
Westerns to an approach whereby Cx43 phosphorylation is
mechanistically linked to changes in Cx43-interacting protein
binding, gap junctional communication, kinase activity and the
underlying signaling pathways affecting cell biological function
[38,39,41,44,47,70,73,86,98,99,101,102]. Furthermore, we are
beginning to be able to sort out different signaling pathways.
Various stimuli can lead to sequential activation of multiple
kinases and changes in Cx43 phosphorylation over time (i.e., ‘‘ki-
nase programs’’). For example, S365 phosphorylation plays a ‘‘gate-
keeper’’ role by preventing downregulation of gap junctional
communication by subsequent Cx43 phosphorylation at S368
[94]. Src activation subsequently leads to Src, MAPK and PKC phos-
phorylation of Cx43 at 6 serines and 2 tyrosines [86] also decreas-
ing gap junction function. Cx43 phosphorylation at casein kinase 1
(CK1) or PKA-related sites causes changes in Cx43 structure that
increase gap junction assembly [44]. These ﬁndings all argue that
an understanding of how coordinated kinase activation and Cx43
phosphorylation regulates gap junction formation and disassemblyunder homeostatic and pathological conditions could lead to
important insights that are translatable to therapeutic interven-
tion. In fact, the anti-arrhythmic peptide rotagaptide (or ZP123)
which is currently being investigated by Zealand Pharma for car-
diovascular use, appears to exert its protective effects through
downstream changes in Cx43 phosphorylation. These peptides
have been shown to inhibit ischemia induced arrhythmia andmyo-
cardial infarct [103,104]. These effects appear to be propagated
through maintenance of Cx43 at the intercalated disc and alter-
ation of the phosphorylation pattern of Cx43 in response to ische-
mia [40,45]. Interaction of Cx43 with PKCa and concomitant
phosphorylation on S368 is a candidate for these effects [103].
However, as discussed above, S368 phosphorylation levels, in mice,
appeared lower during ischemia [41,42], indicating that other
phosphorylation sites may play a role. These types of data show
that Cx43 is a viable, ‘‘druggable’’ target but that a global under-
standing of the kinase programs involved in Cx43 regulation will
be valuable in designing appropriate therapeutics.
Acknowledgments
A Grant from the National Institutes of Health supported the
work presented from the Lampe laboratory (R01GM055632). The
content is solely the responsibility of the authors and does not nec-
essarily represent the ofﬁcial views of the National Institutes of
Health.
References
[1] Goodenough, D.A., Goliger, J.A. and Paul, D.L. (1996) Connexins, connexons,
and intercellular communication. Annu. Rev. Biochem. 65, 475–502.
[2] Bruzzone, R., White, T.W. and Paul, D.L. (1996) Connections with connexins:
the molecular basis of direct intercellular signaling. Eur. J. Biochem. 238, 1–
27.
[3] Willecke, K., Eiberger, J., Degen, J., Eckardt, D., Romualdi, A., Guldenagel, M.,
Deutsch, U. and Sohl, G. (2002) Structural and functional diversity of
connexin genes in the mouse and human genome. Biol. Chem. 383, 725–
737.
[4] Saez, J.C., Berthoud, V.M., Branes, M.C., Martinez, A.D. and Beyer, E.C. (2003)
Plasma membrane channels formed by connexins: their regulation and
functions. Physiol. Rev. 83, 1359–1400.
[5] Sanderson, M.J., Charles, A.C., Boitano, S. and Dirksen, E.R. (1994) Mechanisms
and function of intercellular calcium signaling. Mol. Cell. Endocrinol. 98, 173–
187.
[6] Kelsey, L., Katoch, P., Johnson, K.E., Batra, S.K. and Mehta, P.P. (2012) Retinoids
regulate the formation and degradation of gap junctions in androgen-
responsive human prostate cancer cells. PLoS One 7, e32846.
[7] Kizana, E., Cingolani, E. and Marban, E. (2009) Non-cell-autonomous effects of
vector-expressed regulatory RNAs in mammalian heart cells. Gene Ther. 16,
1163–1168.
[8] Kumar, N.M. and Gilula, N.B. (1996) The gap junction communication
channel. Cell 84, 381–388.
[9] White, T. and Paul, D. (1999) Genetic diseases and gene knockouts reveal
diverse connexin functions. Annu. Rev. Physiol. 61, 283–310.
[10] Dobrowolski, R. and Willecke, K. (2009) Connexin-caused genetic diseases
and corresponding mouse models. Antioxid. Redox Signaling 11, 283–295.
[11] Reaume, A.G. et al. (1995) Cardiac malformation in neonatal mice lacking
connexin43. Science 267, 1831–1834.
[12] Vreeburg, M., de Zwart-Storm, E.A., Schouten, M.I., Nellen, R.G., Marcus-
Soekarman, D., Devies, M., van Geel, M. and van Steensel, M.A. (2007) Skin
changes in oculo-dento-digital dysplasia are correlated with C-terminal
truncations of connexin 43. Am. J. Med. Genet. A 143, 360–363.
[13] Musil, L.S. and Goodenough, D.A. (1993) Multisubunit assembly of an integral
plasma membrane channel protein, gap junction connexin43, occurs after
exit from the ER. Cell 74, 1065–1077.
[14] Saez, J.C., Martinez, A.D., Branes, M.C. and Gonzalez, H.E. (1998) Regulation of
gap junctions by protein phosphorylation. Braz. J. Med. Biol. Res. 31, 593–
600.
[15] Stagg, R.B. and Fletcher, W.H. (1990) The hormone-induced regulation of
contact-dependent cell–cell communication by phosphorylation. Endocr.
Rev. 11, 302–325.
[16] Fishman, G.I., Moreno, A.P., Spray, D.C. and Leinwand, L.A. (1991) Functional
analysis of human cardiac gap junction channel mutants. Proc. Natl. Acad. Sci.
88, 3525–3529.
[17] Moreno, A.P., Chanson, M., Elenes, S., Anumonwo, J., Scerri, I., Gu, H., Taffet,
S.M. and Delmar, M. (2002) Role of the carboxyl terminal of connexin43 in
transjunctional fast voltage gating. Circ. Res. 90, 450–457.
1428 J.L. Solan, P.D. Lampe / FEBS Letters 588 (2014) 1423–1429[18] Maass, K. et al. (2004) Defective epidermal barrier in neonatal mice lacking
the C-terminal region of connexin43. Mol. Biol. Cell 15, 4597–4608.
[19] Goliger, J.A. and Paul, D.L. (1995) Wounding alters epidermal connexin
expression and gap junction-mediated intercellular communication. Mol.
Biol. Cell 6, 1491–1501.
[20] Lampe, P.D., Nguyen, B.P., Gil, S., Usui, M., Olerud, J., Takada, Y. and Carter,
W.G. (1998) Cellular interaction of integrin a3b1 with laminin 5 promotes
gap junctional communication. J. Cell Biol. 143, 1735–1747.
[21] Clark, R.A.F. (1985) Cutaneous tissue repair: basic biological considerations. J.
Am. Acad. Dermatol. 13, 701–725.
[22] Grinnell, F. (1992) Wound repair, keratinocyte activation and integrin
modulation. J. Cell Sci. 101, 1–5.
[23] Saitoh, M., Oyamada, M., Oyamada, Y., Kaku, T. and Mori, M. (1997) Changes
in the expression of gap junction proteins (connexins) in hamster tongue
epithelium during would healing and carcinogenesis. Carcinogenesis 18,
1319–1328.
[24] Fitzgerald, D.J., Fusenig, N.E., Boukamp, P., Piccoli, C., Mesnil, M. and
Yamasaki, H. (1994) Expression and function of connexin in normal and
transformed human keratinocytes in culture. Carcinogenesis 15, 1859–1865.
[25] Wang, C.M., Lincoln, J., Cook, J.E. and Becker, D.L. (2007) Abnormal connexin
expression underlies delayed wound healing in diabetic skin. Diabetes 56,
2809–2817.
[26] Nakano, Y., Oyamada, M., Dai, P., Nakagami, T., Kinoshita, S. and Takamatsu, T.
(2008) Connexin43 knockdown accelerates wound healing but inhibits
mesenchymal transition after corneal endothelial injury in vivo. Invest.
Ophthalmol. Vis. Sci. 49, 93–104.
[27] Kretz, M., Euwens, C., Hombach, S., Eckardt, D., Teubner, B., Traub, O.,
Willecke, K. and Ott, T. (2003) Altered connexin expression and wound
healing in the epidermis of connexin-deﬁcient mice. J. Cell Sci. 116, 3443–
3452.
[28] Qiu, C., Coutinho, P., Frank, S., Franke, S., Law, L.Y., Martin, P., Green, C.R. and
Becker, D.L. (2003) Targeting connexin43 expression accelerates the rate of
wound repair. Curr. Biol. 13, 1697–1703.
[29] Richards, T.S., Dunn, C.A., Carter, W.G., Usui, M.L., Olerud, J.E. and Lampe, P.D.
(2004) Protein kinase C spatially and temporally regulates gap junctional
communication during human wound repair via phosphorylation of
connexin43 on serine368. J. Cell Biol. 167, 555–562.
[30] Revel, J.P. and Karnovsky, M.J. (1967) Hexagonal array of subunits in
intercellular junctions of the mouse heart and liver. J. Cell Biol. 33, C7–C12.
[31] Severs, N.J. (1990) The cardiac gap junction and intercalated disc. Int. J.
Cardiol. 26, 137–173.
[32] Angst, B.D., Khan, L.U., Severs, N.J., Whitely, K., Rothery, S., Thompson, R.P.,
Magee, A.I. and Gourdie, R.G. (1997) Dissociated spatial patterning of gap
junctions and cell adhesion junctions during postnatal differentiation of
ventricular myocardium. Circ. Res. 80, 88–94.
[33] Peters, N.S., Severs, N.J., Rothery, S.M., Lincoln, C., Yacoub, M.H. and Green,
C.R. (1994) Spatiotemporal relation between gap junctions and fascia
adherens junctions during postnatal development of human ventricular
myocardium. Circulation 90, 713–725.
[34] Beardslee, M.A. et al. (2000) Dephosphorylation and intracellular
redistribution of ventricular connexin43 during electrical uncoupling
induced by ischemia. Circ. Res. 87, 656–662.
[35] Jain, S.K., Schuessler, R.B. and Safﬁtz, J.E. (2003) Mechanisms of delayed
electrical uncoupling induced by ischemic preconditioning. Circ. Res. 92,
1138–1144.
[36] Miura, T. et al. (2004) Protective role of gap junctions in preconditioning
against myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 286, H214–
H221.
[37] Schulz, R., Gres, P., Skyschally, A., Duschin, A., Belosjorow, S., Konietzka, I. and
Heusch, G. (2003) Ischemic preconditioning preserves connexin 43
phosphorylation during sustained ischemia in pig hearts in vivo. FASEB J.
17, 1355–1357.
[38] Cooper, C.D. and Lampe, P.D. (2002) Casein kinase 1 regulates connexin43
gap junction assembly. J. Biol. Chem. 277, 44962–44968.
[39] Lampe, P.D., Cooper, C.D., King, T.J. and Burt, J.M. (2006) Analysis of
connexin43 phosphorylated at S325, S328 and S330 in normoxic and
ischemic heart. J. Cell Sci. 119, 3435–3442.
[40] Axelsen, L.N. et al. (2006) Identiﬁcation of ischemia-regulated
phosphorylation sites in connexin43: a possible target for the
antiarrhythmic peptide analogue rotigaptide (ZP123). J. Mol. Cell. Cardiol.
40, 790–798.
[41] Ek-Vitorin, J.F., King, T.J., Heyman, N.S., Lampe, P.D. and Burt, J.M. (2006)
Selectivity of connexin 43 channels is regulated through protein kinase C-
dependent phosphorylation. Circ. Res. 98, 1498–1505.
[42] Hund, T.J., Lerner, D.L., Yamada, K.A., Schuessler, R.B. and Safﬁtz, J.E. (2007)
Protein kinase Cepsilon mediates salutary effects on electrical coupling
induced by ischemic preconditioning. Heart Rhythm 4, 1183–1193.
[43] Sosinsky, G.E., Solan, J.L., Gaietta, G.M., Ngan, L., Lee, G.J., Mackey, M.R. and
Lampe, P.D. (2007) The C-terminus of connexin43 adopts different
conformations in the golgi and gap junction as detected with structure
speciﬁc antibodies. Biochem. J. 408, 375–385.
[44] Solan, J.L., Marquez-Rosado, L., Sorgen, P.L., Thornton, P.J., Gafken, P.R. and
Lampe, P.D. (2007) Phosphorylation of Cx43 at S365 is a gatekeeper event
that changes the structure of Cx43 and prevents downregulation by PKC. J.
Cell Biol. 179, 1301–1309.[45] Jozwiak, J. and Dhein, S. (2008) Local effects and mechanisms of
antiarrhythmic peptide AAP10 in acute regional myocardial ischemia:
electrophysiological and molecular ﬁndings. Naunyn Schmiedebergs Arch.
Pharmacol. 378, 459–470.
[46] Remo, B.F. et al. (2011) Phosphatase-resistant gap junctions inhibit
pathological remodeling and prevent arrhythmias. Circ. Res. 108, 1459–1466.
[47] Johnstone, S.R. et al. (2012) MAPK phosphorylation of connexin 43 promotes
binding of cyclin e and smooth muscle cell proliferation. Circ. Res. 111, 201–
211.
[48] Laird, D.W., Puranam, K.L. and Revel, J.P. (1991) Turnover and
phosphorylation dynamics of connexin43 gap junction protein in cultured
cardiac myocytes. Biochem. J. 273, 67–72.
[49] Crow, D.S., Beyer, E.C., Paul, D.L., Kobe, S.S. and Lau, A.F. (1990)
Phosphorylation of connexin43 gap junction protein in uninfected and
Rous sarcoma virus-transformed mammalian ﬁbroblasts. Mol. Cell. Biol. 10,
1754–1763.
[50] Lampe, P.D. (1994) Analyzing phorbol ester effects on gap junction
communication: a dramatic inhibition of assembly. J. Cell Biol. 127, 1895–
1905.
[51] Musil, L.S., Beyer, E.C. and Goodenough, D.A. (1990) Expression of the gap
junction protein connexin43 in embryonic chick lens: molecular cloning,
ultrastructural localization, and post-translational phosphorylation. J.
Membr. Biol. 116, 163–175.
[52] Beardslee, M., Laing, J., Beyer, E. and Safﬁtz, J. (1998) Rapid turnover of
connexin43 in the adult rat heart. Circ. Res. 83, 629–635.
[53] Darrow, B.J., Laing, J.G., Lampe, P.D., Safﬁtz, J.E. and Beyer, E.C. (1995)
Expression of multiple connexins in cultured neonatal rat ventricular
myocytes. Circ. Res. 76, 381–387.
[54] Chu, F.-F. and Doyle, D. (1985) Turnover of plasma membrane proteins in rat
hepatoma cells and primary cultures of rat hepatocytes. J. Biol. Chem. 260,
3097–3107.
[55] Hare, J.F. and Taylor, K. (1991) Mechanisms of plasma membrane protein
degradation: recycling proteins are degraded more rapidly than those
conﬁned to the cell surface. Proc. Natl. Acad. Sci. USA 88, 5902–5906.
[56] Jordan, K., Solan, J.L., Dominguez, M., Sia, M., Hand, A., Lampe, P.D. and Laird,
D.W. (1999) Trafﬁcking, assembly and function of a connexin43-green
ﬂuorescent protein chimera in live mammalian cells. Mol. Biol. Cell 10, 2033–
2050.
[57] Lauf, U., Giepmans, B.N., Lopez, P., Braconnot, S., Chen, S.C. and Falk, M.M.
(2002) Dynamic trafﬁcking and delivery of connexons to the plasma
membrane and accretion to gap junctions in living cells. Proc. Natl. Acad.
Sci. USA 99, 10446–10451.
[58] Gaietta, G. et al. (2002) Multicolor and electron microscopic imaging of
connexin trafﬁcking. Science 296, 503–507.
[59] Archard, H.O. and Denys, F.R. (1979) Development of annular gap junctions in
guinea pig epithelia. J. Oral Pathol. 8, 187–197.
[60] Fong, J.T., Kells, R.M., Gumpert, A.M., Marzillier, J.Y., Davidson, M.W. and Falk,
M.M. (2012) Internalized gap junctions are degraded by autophagy.
Autophagy 8, 794–811.
[61] Johnson, K.E., Mitra, S., Katoch, P., Kelsey, L.S., Johnson, K.R. and Mehta, P.P.
(2013) Phosphorylation on Ser-279 and Ser-282 of connexin43 regulates
endocytosis and gap junction assembly in pancreatic cancer cells. Mol. Biol.
Cell 24, 715–733.
[62] Jordan, K., Chodock, R., Hand, A.R. and Laird, D.W. (2001) The origin of
annular junctions: a mechanism of gap junction internalization. J. Cell Sci.
114, 763–773.
[63] Leithe, E., Brech, A. and Rivedal, E. (2006) Endocytic processing of connexin43
gap junctions: a morphological study. Biochem. J. 393, 59–67.
[64] Nickel, B., Boller, M., Schneider, K., Shakespeare, T., Gay, V. and Murray, S.A.
(2013) Visualizing the effect of dynamin inhibition on annular gap vesicle
formation and ﬁssion. J. Cell Sci. 126, 2607–2616.
[65] Piehl, M., Lehmann, C., Gumpert, A., Denizot, J.P., Segretain, D. and Falk, M.M.
(2007) Internalization of large double-membrane intercellular vesicles by a
clathrin-dependent endocytic process. Mol. Biol. Cell 18, 337–347.
[66] Severs, N.J., Shovel, K.S., Slade, A.M., Powell, T., Twist, V.W. and Green, C.R.
(1989) Fate of gap junctions in isolated adult mammalian cardiomyocytes.
Circ. Res. 65, 22–42.
[67] Laird, D.W. (2006) Life cycle of connexins in health and disease. Biochem. J.
394, 527–543.
[68] Duffy, H.S., Delmar, M. and Spray, D.C. (2002) Formation of the gap junction
nexus: binding partners for connexins. J. Physiol. Paris 96, 243–249.
[69] Atkinson, M.M., Lampe, P.D., Lin, H.H., Kollander, R., Li, X.-R. and Kiang, D.T.
(1995) Cyclic AMP modiﬁes the cellular distribution of connexin 43 and
induces a persistent increase in the junctional permeability of mouse
mammary tumor cells. J. Cell Sci. 108, 3079–3090.
[70] TenBroek, E.M., Lampe, P.D., Solan, J.L., Reynhout, J.K. and Johnson, R.G.
(2001) Ser364 of connexin43 and the upregulation of gap junction assembly
by cAMP. J. Cell Biol. 155, 1307–1318.
[71] Li, W.E., Ochalski, P.A., Hertzberg, E.L. and Nagy, J.I. (1998)
Immunorecognition, ultrastructure and phosphorylation status of astrocytic
gap junctions and connexin43 in rat brain after cerebral focal ischaemia. Eur.
J. Neurosci. 10, 2444–2463.
[72] Park, D.J., Wallick, C.J., Martyn, K.D., Lau, A.F., Jin, C. and Warn-Cramer, B.J.
(2007) Akt phosphorylates connexin43 on Ser373, a ‘‘mode-1’’ binding site
for 14-3-3. Cell Commun. Adhes. 14, 211–226.
J.L. Solan, P.D. Lampe / FEBS Letters 588 (2014) 1423–1429 1429[73] Dunn, C.A., Su, V., Lau, A.F. and Lampe, P.D. (2012) Activation of Akt, not
connexin 43 protein ubiquitination, regulates gap junction stability. J. Biol.
Chem. 287, 2600–2607.
[74] Dunn, C.A. and Lampe, P.D. (2013) Injury-triggered Akt phosphorylation of
Cx43: a ZO-1-driven a molecular switch that regulates gap junction size. J.
Cell Sci. (Nov 8), http://dx.doi.org/10.1242/jcs.142497 [Epub ahead of print].
[75] Hunter, A.W., Barker, R.J., Zhu, C. and Gourdie, R.G. (2005) Zonula occludens-1
alters connexin43 gap junction size and organization by inﬂuencing channel
accretion. Mol. Biol. Cell 16, 5686–5698.
[76] O’Quinn, M.P., Palatinus, J.A., Harris, B.S., Hewett, K.W. and Gourdie, R.G.
(2011) A peptide mimetic of the connexin43 carboxyl terminus reduces gap
junction remodeling and induced arrhythmia following ventricular injury.
Circ. Res. 108, 704–715.
[77] Palatinus, J.A., Rhett, J.M. and Gourdie, R.G. (2011) Enhanced PKCepsilon
mediated phosphorylation of connexin43 at serine 368 by a carboxyl-
terminal mimetic peptide is dependent on injury. Channels (Austin) 5, 236–
240.
[78] Becker, D.L., Thrasivoulou, C. and Phillips, A.R. (2012) Connexins in wound
healing; perspectives in diabetic patients. Biochim. Biophys. Acta 1818,
2068–2075.
[79] Coutinho, P., Qiu, C., Frank, S., Tamber, K. and Becker, D. (2003) Dynamic
changes in connexin expression correlate with key events in the wound
healing process. Cell Biol. Int. 27, 525–541.
[80] Sorgen, P.L., Duffy, H.S., Sahoo, P., Coombs, W., Delmar, M. and Spray, D.C.
(2004) Structural changes in the carboxyl terminus of the gap junction
protein connexin43 indicates signaling between binding domains for c-Src
and zonula occludens-1. J. Biol. Chem. 279, 54695–54701.
[81] Toyofuku, T., Akamatsu, Y., Zhang, H., Kuzuya, T., Tada, M. and Hori, M. (2001)
C-Src regulates the interaction between connexin-43 and ZO-1 in cardiac
myocytes. J. Biol. Chem. 276, 1780–1788.
[82] Atkinson, M.M. and Sheridan, J.D. (1988) Altered junctional permeability
between cells transformed by v-ras, v-mos or v-src. Am. J. Physiol. 255, C674–
C683.
[83] Azarnia, R. and Loewenstein, W.R. (1984) Intercellular communication and
control of cell growth. X. Alteration of junctional permeability by the src
gene. J. Membr. Biol. 82, 191–205.
[84] Lin, R., Warn-Cramer, B.J., Kurata, W.E. and Lau, A.F. (2001) v-Src
phosphorylation of connexin 43 on Tyr247 and Tyr265 disrupts gap
junctional communication. J. Cell Biol. 154, 815–827.
[85] Swenson, K.I., Piwnica-Worms, H., McNamee, H. and Paul, D.L. (1990)
Tyrosine phosphorylation of the gap junction protein connexin43 is
required for pp60src-induced inhibition of communication. Cell Regul. 1,
989–1002.
[86] Solan, J.L. and Lampe, P.D. (2008) Connexin 43 in LA-25 cells with active v-src
is phosphorylated on Y247, Y265, S262, S279/282, and S368 via multiple
signaling pathways. Cell Commun. Adhes. 15, 75–84.
[87] Moreno, A.P. and Lau, A.F. (2007) Gap junction channel gating modulated
through protein phosphorylation. Prog. Biophys. Mol. Biol. 94, 107–119.
[88] Cottrell, G.T., Lin, R., Warn-Cramer, B.J., Lau, A.F. and Burt, J.M. (2003)
Mechanism of v-Src- and mitogen-activated protein kinase-induced
reduction of gap junction communication. Am. J. Physiol. Cell Physiol. 284,
C511–C520.
[89] Zhou, L., Kasperek, E.M. and Nicholson, B.J. (1999) Dissection of the molecular
basis of pp60(v-src) induced gating of connexin 43 gap junction channels. J.
Cell Biol. 144, 1033–1045.
[90] Kalcheva, N. et al. (2007) Gap junction remodeling and cardiac
arrhythmogenesis in a murine model of oculodentodigital dysplasia. Proc.
Natl. Acad. Sci. USA 104, 20512–20516.
[91] Qu, J., Volpicelli, F.M., Garcia, L.I., Sandeep, N., Zhang, J., Marquez-Rosado, L.,
Lampe, P.D. and Fishman, G.I. (2008) Gap junction remodeling and
spironolactone-dependent reverse remodeling in the hypertrophied heart.
Circ. Res. 104, 365–371.
[92] Kanemitsu, M.Y., Loo, L.W., Simon, S., Lau, A.F. and Eckhart, W. (1997)
Tyrosine phosphorylation of connexin 43 by v-Src is mediated by SH2 and
SH3 domain interactions. J. Biol. Chem. 272, 22824–22831.
[93] Palatinus, J.A., O’Quinn, M.P., Barker, R.J., Harris, B.S., Jourdan, J. and Gourdie,
R.G. (2011) ZO-1 determines adherens and gap junction localization at
intercalated disks. Am. J. Physiol. Heart Circ. Physiol. 300, H583–H594.
[94] Solan, J.L. and Lampe, P.D. (2005) Connexin phosphorylation as a regulatory
event linked to gap junction channel assembly. Biochim. Biophys. Acta 1711,
154–163.[95] King, T.J. and Lampe, P.D. (2005) Temporal regulation of connexin
phosphorylation in embryonic and adult tissues. Biochim. Biophys. Acta
1719, 24–35.
[96] Solan, J.L. and Lampe, P.D. (2007) Key connexin 43 phosphorylation events
regulate the gap junction life cycle. J. Membr. Biol. 217, 35–41.
[97] Singh, D., Solan, J.L., Taffet, S.M., Javier, R. and Lampe, P.D. (2005) Connexin 43
interacts with zona occludens-1 and -2 proteins in a cell cycle stage-speciﬁc
manner. J. Biol. Chem. 280, 30416–30421.
[98] Marquez-Rosado, L., Singh, D., Rincon-Arano, H., Solan, J.L. and Lampe, P.D.
(2012) CASK (LIN2) interacts with Cx43 in wounded skin and their
coexpression affects cell migration. J. Cell Sci. 125, 695–702.
[99] Johnstone, S.R., Ross, J., Rizzo, M.J., Straub, A.C., Lampe, P.D., Leitinger, N. and
Isakson, B.E. (2009) Oxidized phospholipid species promote in vivo
differential cx43 phosphorylation and vascular smooth muscle cell
proliferation. Am. J. Pathol. 175, 916–924.
[100] Sin, W.C., Tse, M., Planque, N., Perbal, B., Lampe, P.D. and Naus, C.C. (2009)
Matricellular protein CCN3 (NOV) regulates actin cytoskeleton
reorganization. J. Biol. Chem. 284, 29935–29944.
[101] Chen, S.C., Kennedy, B.K. and Lampe, P.D. (2013) Phosphorylation of
connexin43 on S279/282 may contribute to laminopathy-associated
conduction defects. Exp. Cell Res. 319, 888–896.
[102] Dyce, P.W., Norris, R.P., Lampe, P.D. and Kidder, G.M. (2012) Phosphorylation
of serine residues in the C-terminal cytoplasmic tail of connexin43 regulates
proliferation of ovarian granulosa cells. J. Membr. Biol. 245, 291–301.
[103] Dhein, S., Hagen, A., Jozwiak, J., Dietze, A., Garbade, J., Barten, M., Kostelka, M.
and Mohr, F.W. (2010) Improving cardiac gap junction communication as a
new antiarrhythmic mechanism: the action of antiarrhythmic peptides.
Naunyn Schmiedebergs Arch. Pharmacol. 381, 221–234.
[104] Hennan, J.K. et al. (2006) Rotigaptide (ZP123) prevents spontaneous
ventricular arrhythmias and reduces infarct size during myocardial
ischemia/reperfusion injury in open-chest dogs. J. Pharmacol. Exp. Ther.
317, 236–243.
[105] Warn-Cramer, B.J., Lampe, P.D., Kurata, W.E., Kanemitsu, M.Y., Loo, L.W.M.,
Eckhart, W. and Lau, A.F. (1996) Characterization of the MAP kinase
phosphorylation sites on the connexin43 gap junction protein. J. Biol.
Chem. 271, 3779–3786.
[106] Doble, B.W., Dang, X., Ping, P., Fandrich, R.R., Nickel, B.E., Jin, Y., Cattini, P.A.
and Kardami, E. (2004) Phosphorylation of serine 262 in the gap junction
protein connexin-43 regulates DNA synthesis in cell–cell contact forming
cardiomyocytes. J. Cell Sci. 117, 507–514.
[107] Lampe, P.D., Kurata, W.E., Warn-Cramer, B. and Lau, A.F. (1998) Formation of
a distinct connexin43 phosphoisoform in mitotic cells is dependent upon
p34cdc2 kinase. J. Cell Sci. 111, 833–841.
[108] Kanemitsu, M.Y., Jiang, W. and Eckhart, W. (1998) Cdc2-mediated
phosphorylation of the gap junction protein, connexin43, during mitosis.
Cell Growth Differ. 9, 13–21.
[109] Procida, K., Jorgensen, L., Schmitt, N., Delmar, M., Taffet, S.M., Holstein-
Rathlou, N.H., Nielsen, M.S. and Braunstein, T.H. (2009) Phosphorylation of
connexin43 on serine 306 regulates electrical coupling. Heart Rhythm 6,
1632–1638.
[110] Bonnette, P.C., Robinson, B.S., Silva, J.C., Stokes, M.P., Brosius, A.D., Baumann,
A. and Buckbinder, L. (2010) Phosphoproteomic characterization of PYK2
signaling pathways involved in osteogenesis. J. Proteomics 73, 1306–1320.
[111] Ballif, B.A., Carey, G.R., Sunyaev, S.R. and Gygi, S.P. (2008) Large-scale
identiﬁcation and evolution indexing of tyrosine phosphorylation sites from
murine brain. J. Proteome Res. 7, 311–318.
[112] Shah, M.M., Martinez, A.-M. and Fletcher, W.H. (2002) The connexin43 gap
junction protein is phosphorylated by protein kinase A and protein kinase C:
in vivo and in vtitro studies. Mol. Cell. Biochem. 238, 57–68.
[113] Yogo, K., Ogawa, T., Akiyama, M., Ishida, N. and Takeya, T. (2002)
Identiﬁcation and functional analysis of novel phosphorylation sites in
Cx43 in rat primary granulosa cells. FEBS Lett. 531, 132–136.
[114] Lampe, P.D., TenBroek, E.M., Burt, J.M., Kurata, W.E., Johnson, R.G. and Lau,
A.F. (2000) Phosphorylation of connexin43 on serine368 by protein kinase C
regulates gap junctional communication. J. Cell Biol. 126, 1503–1512.
[115] Saez, J.C., Nairn, A.C., Czernik, A.J., Fishman, G.I., Spray, D.C. and Hertzberg,
E.L. (1997) Phosphorylation of connexin43 and the regulation of neonatal rat
cardiac myocyte gap junctions. J. Mol. Cell. Cardiol. 29, 2131–2145.
[116] Dunn, C.A. and Lampe, P.D. (2014) Injury-triggered Akt phosphorylation of
Cx43: a ZO-1-driven molecular switch that regulates gap junction size. J. Cell
Sci. 127, 455–464.
